Thanks to @NatRevMCB for inviting me to highlight the paper that brought us direct-RNA-seq. It has been exciting using "my precious" nanopore to map RNA modifications.
1/n What fraction of the human genome is essential for cellular viability?
Excited to share our preprint that explores this question by combining an unusual CRISPR system, phage promoters, and thousands of deletion launchpads.
@sudpinglay@JShendure
https://t.co/rTO1MyFv3q
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
Now out in @NatureBiotech ! Do lncRNAs commonly bind 1000s of genomic sites? Maybe they do, but the dozens of studies that report genomic binding maps of lncRNAs are deeply flawed, with probes binding suprious DNA sites rather than RNA-bound ones. https://t.co/01NroM67dK
Probably Craig Venters last interview.
The people who drone on about the necessity of NIH “basic science” are the duds and dropouts of the class.
It’s food stamps for the underachievers.
@fchollet You are my AI hero. However, I disagree about biology. At this moment, we need more high-quality data, the proper measures, and relevant questions. I actually wrote about this earlier today https://t.co/q3LZlOIPja
Our new discovery that bacteria utilize extracellular vesicles to deliver RNAs into fungi substantially broadens the paradigm of Cross-Kingdom RNA communication! Big congrats to @J_NinoSanchez, @HuaitongW and all! Thanks for your hard work! https://t.co/7OAMaItcxa
Just finished giving the last talk at this amazing Asian RNA Club Symposium that was full of other talks and posters with new unpublished stories. Looking forward to the next Symposium in 2 years at Nara, Japan!
I was amazed by this tour de force to profile 16 different RNA modifications simultaneously when i first heard @SchragaSchwartz talk about it. I'm still amazed now.
https://t.co/tQ1bWCHLZy
Always great to have old friends visit us in SZ. Today, fellow HannonLab alumnus @Elvin_Wag from @IcahnMountSinai visited us at @ShenzhenBayLab to share his experience researching cancer stem cells, give career advice to our young scientists and enjoy our famous roast pigeon